ask="0.6950"
ask_size="1500"
average_daily_volume="3842640"
bid="0.6750"
bid_size="41200"
book_value="0.1680"
change="+0.1118"
change_from_200_day_moving_average="0.3889"
change_from_50_day_moving_average="0.3037"
change_from_52_week_high="-0.0112"
change_From_52_week_low="0.4808"
change_in_percent="+17.1736%"
close="0.7628"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.2960"
ebitda="-41.64M"
eps_estimate_current_year="-0.1300"
eps_estimate_next_quarter="-0.0300"
eps_estimate_next_year="-0.2100"
ex_dividend_date="N/A"
float_shares="229462000"
high="0.7740"
high_52_weeks="0.7740"
last_trade_date="3/13/2017"
last_trade_price="0.7628"
last_trade_size="22200"
last_trade_time="4:00pm"
low="0.6500"
low_52_weeks="0.2820"
market_capitalization="196.15M"
moving_average_200_day="0.3739"
moving_average_50_day="0.4591"
name="Peregrine Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="1.0000"
open="0.6550"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="+104.0134%"
percent_change_from_50_day_moving_average="+66.1356%"
percent_change_from_52_week_high="-1.4470%"
percent_change_from_52_week_low="+170.4964%"
previous_close="0.6510"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.8750"
price_per_sales="3.0732"
revenue="54.47M"
shares_outstanding="257141000"
short_ratio="0.2600"
stock_exchange="NCM"
symbol="PPHM"
volume="6555670"
weeks_range_52="0.2820 - 0.7740"
